Jan Erik Alenfall

Jan Erik Alenfall

Chief Executive Officer at Callipa AB

62 year
Health Technology

Profile

Jan Erik Alenfall is currently the Managing Director & Director at Callipa AB.
Previously, he worked as the Chief Executive Officer & Director at DermaGen AB, Head-Research at Probi AB, Manager-International Clinical Research at Ferring Pharmaceuticals A, Associate-Clinical Research at Pharmacia AB, Head-Clinical & Preclinical Research at Trettiosjucorp AB, Manager-International Clinical Research at Rechon Life Science AB, and Head-Clinical & Preclinical Research at SkyePharma AB.
He also served as the Chief Scientific Officer at Follicum AB from 2013 to 2021.

Jan Erik Alenfall active positions

CompaniesPositionStart
Callipa AB Chief Executive Officer -
All active positions of Jan Erik Alenfall

Former positions of Jan Erik Alenfall

CompaniesPositionEnd
FOLLICUM AB (PUBL) Chief Executive Officer 2021-04-05
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jan Erik Alenfall's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jan Erik Alenfall's experience

Connections

13

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
PROBI AB

Health Technology

Private companies8

Health Technology

Pharmacia AB

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Callipa AB

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Jan Erik Alenfall